Join ARM, along with the Hemophilia Federation of America and the National Hemophilia Foundation, in Washington, D.C. on December 13 to learn about the latest scientific progress and delivery challenges associated with hemophilia and other inherited blood disorders. 

ARM'S Q3 2016 QUARTERLY DATA REPORT DETAILS INDUSTRY-SPECIFIC STATISTICS COMPILED FROM MORE THAN 730 LEADING GENE THERAPY, CELL THERAPY AND OTHER REGENERATIVE MEDICINE COMPANIES WORLDWIDE. 

 

Join over 300 attendees on Monday, January 9 for ARM's Annual Cell & Gene Therapies State of the Industry Briefing. Don't miss your chance to attend the largest cell and gene therapy-focused annual gathering taking place in San Francisco during JP Morgan week!

About ARM

Advancing Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations.
Learn more

Our Members

200+ and Growing
ARM’s membership is diverse, representing leading regenerative medicine companies and investors, university-based and non-profit research institutions, patient advocacy groups, pharmaceutical companies engaged in regenerative medicine research and other organizations supporting regenerative medicine.
Learn more